Joong Myung Cho – Chairman & CEO, CrystalGenomics, South Korea
Joong Myung Cho of Korean biotech success story CrystalGenomics introduces the company’s unique drug discovery…
Address: 15F, Haesung-2-building, Teheran-Ro 508, Gangnam-gu ,Seoul, Republic of Korea 135-725
Tel: +82-2-2185-3800
Web: http://www.merck.co.kr/en/index.html;jsessionid=BD027DF767B36C40BA9C1C74E6E903E9
Merck Republic of Korea, a Republic of Korean subsidiary of Merck KGaA Germany, a global research-driven pharmaceutical company dedicated to putting patients first; Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. Merck Republic of Korea Ltd. was founded in 1989 and established Merck Advanced Technologies Ltd. (MAT) in 2002 to better serve the Republic of Korean display industry. In the same year, an R&D and production center for liquid crystals and a warehouse were opened in Poseung.Earlier in 2009, Merck announced it is investing 14 billion Republic of Korean Won (? 11 million) to establish an Advanced Technology Center in Republic of Korea to improve it’s R&D and manufacturing capacities.
Joong Myung Cho of Korean biotech success story CrystalGenomics introduces the company’s unique drug discovery…
Young-Shik Cho, chairman of SD Biosensor, recounts his journey leading diagnostics companies and expanding their…
The completion of the Human Genome Project (HGP) in April 2003 with the publication of the first human genome…
Dr Jeong-Sun Seo, chairman of Macrogen & president of the Korea Biotechnology Industry Organization (KoreaBIO),…
Gencurix was the first Asian company to develop a prognostic diagnostic test for breast cancer. Its CEO, Dr Sangrae…
Yeul-Hong Kim, Director of K-MASTER details the project’s success in creating a shared database of genomic data…
Korean biosimilar firm Celltrion’s USD 266 million acquisition of Japanese outfit Takeda assets in the…
Under the stewardship of regenerative medicine industry veteran BG Rhee, Korean firm SCM Lifescience has engaged in…
Genome & Company, with a market cap of USD 280 million, is the highest valued microbiome company worldwide. Dr…
After failing to attain reimbursement for its Amyotrophic Lateral Sclerosis (ALS) treatment NEURONATA-R® in Korea,…
Kyung Suk Kim, CEO of Corestem, the first company to receive approval for a stem cell therapy for Amyotrophic…
With over 30 years of experience in public office working in public health and pharmaceutical policy, food and drug…